Maria J. Escudero
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Correction: Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 25, 2025
Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM).
Journal: Therapeutic advances in medical oncology
Published: July 18, 2025
Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: October 27, 2023
Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force.
Journal: ESMO open
Published: March 11, 2022
Performance of a Direct Methane Solid Oxide Fuel Cell Using Nickel-Ceria-Yttria Stabilized Zirconia as the Anode.
Journal: Materials (Basel, Switzerland)
Published: December 19, 2019
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 06, 2019
Evolution of older patients diagnosed with early breast cancer in Spain between 1998 and 2001 included in El Alamo III project.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: May 20, 2019
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2-) early breast cancer (EBC): results from the GEICAM/2006-10 study.
Journal: Breast cancer research and treatment
Published: February 04, 2019
Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study.
Journal: Breast cancer research and treatment
Published: December 07, 2018
Critically short telomeres and toxicity of chemotherapy in early breast cancer.
Journal: Oncotarget
Published: October 25, 2016
Last Updated: 09/26/2026